Dermoscopic Examination of Moles (Epiluminescence Microscopy)

The dermoscopic examination of moles using epiluminescence is a screening test aimed at the prevention of melanoma, a type of skin cancer responsible for approximately 1.5% of all cancer-related deaths, through the analysis of moles via telemedicine.

Exposure to the ultraviolet (UV) component of sunlight is the main risk factor for the development of melanoma. Monitoring "at-risk" moles is the primary preventive strategy against this type of cancer.

At-risk moles are those that show atypical features upon clinical and dermatoscopic examination — typically moles that are:

• large in size,
• with indistinct or irregular borders,
• variable in color,
• with a slightly raised or smooth surface,
• shaped like an “egg” (with a darker, raised central area surrounded by a lighter, flat area).

It is estimated that individuals with 51 to 100 total moles have a threefold increased risk of developing melanoma, while those with more than 100 moles have a sixfold higher risk.

Moreover, individuals with atypical moles but no personal or family history of melanoma have a 7- to 27-fold increased risk of developing melanoma — a risk that rises significantly in the presence of family history.

The mole examination service offered in pharmacies is carried out using a device called a dermatoscope, which resembles a digital camera but, thanks to its high resolution and epiluminescence technology, can capture detailed images of the moles to be analyzed. These images are then remotely evaluated by a dermatologist through teledermatology.

Booking is required

Appointments can be scheduled online or by phone.